Pamrevlumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pamrevlumab" in English language version.

refsWebsite

Global rank English rank

195^th place

302^nd place

2^nd place

2^nd place

4^th place

4^th place

1semanticscholar.org

11^th place

8^th place

3,257^th place

3,398^th place

ama-assn.org

searchusan.ama-assn.org

Statement On A Nonproprietary Name Adopted By The USAN Council - Pamrevlumab, American Medical Association.

doi.org

Sgalla G, Franciosa C, Simonetti J, Richeldi L (August 2020). "Pamrevlumab for the treatment of idiopathic pulmonary fibrosis". Expert Opinion on Investigational Drugs. 29 (8): 771–777. doi:10.1080/13543784.2020.1773790. PMID 32447983. S2CID 218873298.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sgalla G, Franciosa C, Simonetti J, Richeldi L (August 2020). "Pamrevlumab for the treatment of idiopathic pulmonary fibrosis". Expert Opinion on Investigational Drugs. 29 (8): 771–777. doi:10.1080/13543784.2020.1773790. PMID 32447983. S2CID 218873298.

semanticscholar.org

api.semanticscholar.org

Sgalla G, Franciosa C, Simonetti J, Richeldi L (August 2020). "Pamrevlumab for the treatment of idiopathic pulmonary fibrosis". Expert Opinion on Investigational Drugs. 29 (8): 771–777. doi:10.1080/13543784.2020.1773790. PMID 32447983. S2CID 218873298.

who.int

World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113" (PDF). WHO Drug Information. 29 (2).